Kvolik 2012a.
Methods |
Study design: prospective, randomized study Sample size calculation: no information available |
|
Participants |
Number of randomized participants: 36 Inclusion criteria: undergoing thyroidectomy Exclusion criteria: no information available |
|
Interventions |
Anaesthesia: propofol and fentanyl for both induction and maintenance NMBA: single intubating dose: rocuronium 0.6 mg/kg; maintenance dose: rocuronium 0.1 mg/kg Comparison: sugammadex 2 mg/kg (n = 17) vs neostigmine 50 µg/kg (n = 19) Administration time of sugammadex or neostigmine: reappearance of T2 |
|
Outcomes | Recovery of TOFR > 90% of baseline, recovery of cough reflexes enabling safe extubation, spontaneous minute volume at the time of extubation | |
Notes |
Publication type: meeting abstract Country: Croatia Conversions: none Handling of adverse events: No discrepancy exists between AEs presented in the meeting abstract and those reported in this review Authors’ conclusions: Recovery of cough reflexes was faster and respiration more efficient in patients receiving sugammadex. A safe extubation was determined by age, TOF recovery, and effects of other anaesthetics Contact: first trial author Slavica Kvolik contacted by email: slavica.kvolik@os.t‐com.hr on 14.10.2015; no reply received |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | "Randomized"; no further information available |
Allocation concealment (selection bias) | Unclear risk | Unable to assess owing to insufficient information |
Blinding of participants (performance bias) | Unclear risk | Unable to assess owing to insufficient information |
Blinding of personnel (performance bias) | Unclear risk | Unable to assess owing to insufficient information |
Blinding of primary outcome assessment (detection bias) | Unclear risk | Unable to assess owing to insufficient information |
Blinding of safety assessment (detection bias) | Unclear risk | Unable to assess owing to insufficient information |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Unable to assess owing to insufficient information |
Selective reporting (reporting bias) | Low risk | Study protocol not available, but published meeting abstract clearly includes all expected outcomes |
Funding bias | Unclear risk | Unable to assess owing to insufficient information |
Other bias | Unclear risk | No information on sample size calculation. No differences regarding participant characteristics and preparative FT4, FT3, and TSH levels between groups |